Selected Publications

Magalhães J., Eira J., Liz M.A.,

The role of transthyretin in cell biology: impact on human pathophysiology. Cellular and Molecular Life Sciences78(17-18):6105-6117, 2021. [Journal: Review] [CI: 12] [IF: 9,2]
DOI: 10.1007/s00018-021-03899-3 SCOPUS: 85111151460.

Magalhaes J., Tresse E., Ejlerskov P., Hu E., Liu Y., Marin A., Montalant A., Satriano L., Rundsten C.F., Carlsen E.M.M., Rydbirk R., Sharifi-Zarchi A., Andersen J.B., Aznar S., Brudek T., Khodosevich K., Prinz M., Perrier J.F.M., Sharma M., Gasser T., Issazadeh-Navikas S.,

PIAS2-mediated blockade of IFN-ß signaling: a basis for sporadic Parkinson disease dementia. Molecular Psychiatry26(10):6083-6099, 2021. [Journal: Article] [CI: 20] [IF: 13,4]
DOI: 10.1038/s41380-021-01207-w SCOPUS: 85110009586.

Eira J., Magalhães J., Macedo N., Pero M.E., Misgeld T., Sousa M.M., Bartolini F., Liz M.A.,

Transthyretin Promotes Axon Growth via Regulation of Microtubule Dynamics and Tubulin Acetylation. Frontiers in Cell and Developmental Biology9:, 2021. [Journal: Article] [CI: 6] [IF: 6,1]
DOI: 10.3389/fcell.2021.747699 SCOPUS: 85119698656.

McNeill A., Magalhaes J., Shen C., Chau K.Y., Hughes D., Mehta A., Foltynie T., Cooper J.M., Abramov A.Y., Gegg M., Schapira A.H.V.,

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain137(5):1481-1495, 2014. [Journal: Article] [CI: 239] [IF: 9,2]
DOI: 10.1093/brain/awu020 SCOPUS: 84899819100.

Magalhaes J., Gegg M.E., Migdalska-Richards A., Doherty M.K., Whitfield P.D., Schapira A.H.V.,

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: Relevance to Parkinson disease. Human Molecular Genetics25(16):3432-3445, 2016. [Journal: Article] [CI: 156] [IF: 5,3]
DOI: 10.1093/hmg/ddw185 SCOPUS: 84994143522.